Impaired humoral immunity to BQ.1.1 in convalescent and vaccinated patients

Determining SARS-CoV-2 immunity is critical to assess COVID-19 risk and the need for prevention and mitigation strategies. We measured SARS-CoV-2 Spike/Nucleocapsid seroprevalence and serum neutralizing activity against Wu01, BA.4/5 and BQ.1.1 in a convenience sample of 1,411 patients receiving medi...

Descripción completa

Detalles Bibliográficos
Autores principales: Dewald, Felix, Pirkl, Martin, Paluschinski, Martha, Kühn, Joachim, Elsner, Carina, Schulte, Bianca, Knüfer, Jacqueline, Ahmadov, Elvin, Schlotz, Maike, Oral, Göksu, Bernhard, Michael, Michael, Mark, Luxenburger, Maura, Andrée, Marcel, Hennies, Marc Tim, Hafezi, Wali, Müller, Marlin Maybrit, Kümpers, Philipp, Risse, Joachim, Kill, Clemens, Manegold, Randi Katrin, von Frantzki, Ute, Richter, Enrico, Emmert, Dorian, Monzon-Posadas, Werner O., Gräff, Ingo, Kogej, Monika, Büning, Antonia, Baum, Maximilian, Teipel, Finn, Mochtarzadeh, Babak, Wolff, Martin, Gruell, Henning, Di Cristanziano, Veronica, Burst, Volker, Streeck, Hendrik, Dittmer, Ulf, Ludwig, Stephan, Timm, Jörg, Klein, Florian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10199003/
https://www.ncbi.nlm.nih.gov/pubmed/37208323
http://dx.doi.org/10.1038/s41467-023-38127-y

Ejemplares similares

Ejemplares similares